Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|September 23, 2008
Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinibTiziana Servidei, Anna Riccardi, Simona Mozzetti, et al.
Biological Procedures Online|May 8, 2003
Semiquantitative RT-PCR analysis to assess the expression levels of multiple transcripts from the same sampleMaria Marone, Simona Mozzetti, Daniela De Ritis, et al.
Biochemical Pharmacology|December 14, 2004
Thiocolchicine dimers: a novel class of topoisomerase-I inhibitorsGiuseppina Raspaglio, Cristiano Ferlini, Simona Mozzetti, et al.
Molecular Cancer Therapeutics|June 21, 2008
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cellsMichela Muscolini, Roberta Cianfrocca, Angela Sajeva, et al.
Current Cancer Drug Targets|January 29, 2008
Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work?Cristiano Ferlini, Giuseppina Raspaglio, Lucia Cicchillitti, et al.
Leukemia & Lymphoma|May 11, 2002
Cell cycle regulation in human hematopoietic stem cells: from isolation to activationMaria Marone, Daniela De Ritis, Giuseppina Bonanno, et al.
Oncology Research|December 15, 2010
RON and cisplatin resistance in ovarian cancer cell linesSilvia Prislei, Marisa Mariani, Giuseppina Raspaglio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patientsGabriella Ferrandina, Gian Franco Zannoni, Enrica Martinelli, et al.
Molecular Cancer Therapeutics|January 12, 2008
From plasma membrane to cytoskeleton: a novel function for semaphorin 6ASilvia Prislei, Simona Mozzetti, Flavia Filippetti, et al.
Pageof 3